On January 3, 2018, following reports that processor chips manufactured by AMD’s competitor, Intel Corporation, contained a major security flaw—known as the “Spectre” vulnerability—AMD advised investors that while its own chips were vulnerable to one variant of Spectre, there was “near zero risk” that AMD chips were vulnerable to the second Spectre variant. Then, on January 11, 2018, post-market, AMD acknowledged that its chips were, in fact, susceptible to both variants of the Spectre security flaw. On this news, AMD’s share price has fallen sharply during intraday trading on January 12, 2018.

If you are aware of any facts relating to this investigation, or purchased shares of AMD, you can assist this investigation by visiting the firm’s site: www.bgandg.com/amd. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.